Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1864663 (
HCC
)
2,985
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Although
KIAA0101
is involved in many diseases, its expression and prognostic value in
HCC
remain undefined. According to CCLE,
KIAA0101
is highly expressed in
HCC
, with a weak positive correlation between copy number and gene expression. Four studies involving 760 samples in ONCOMINE report elevated
KIAA0101
expression in
HCC
(p=3.11E-22). The KM plotter revealed high
KIAA0101
expression to be associated with worse overall survival in
HCC
(HR=2.09, p=4.1e-05); this prognostic power was stronger for male than female, early-stage than advanced-stage, and Asian than Caucasian patients. RNA sequencing data for 8 pairs of
HCC
and adjacent tissue samples validated the significantly high
KIAA0101
level (p=0.00497). Moreover, functional annotations of 31
KIAA0101
-coexpressed genes show enrichment of terms associated with mitosis, cytoskeleton construction, and chromosome segregation. Among 9 genes having STRING-validated protein-protein interactions with
KIAA0101
, two are involved in virus-related pathways. Alternative splicing analysis indicated higher expression of variant 1 and variant 2 in
HCC
and no significant differences in exon usage of
KIAA0101
between cancer and normal tissues. These findings support that
KIAA0101
is a potential prognostic biomarker for
HCC
and highlight the association between virus infection and the mechanism underlying the process by which
KIAA0101
contributes to poor prognosis of patients.
...
PMID:Prognostic value and underlying mechanism of KIAA0101 in hepatocellular carcinoma: database mining and co-expression analysis. 3285 64